Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: So, are most that have heard the conference

I agree ARNA investors is a factor, but I believe AMLN buyout has been the real driver. It narrows the feild of potential acquisitions/partnerships in the diabetes space.

Share
New Message
Please login to post a reply